Target intelligence / Profile preview

Thymosin beta 10 pseudogene 2 (TMSB10P2)

Target
TMSB10P2
Molecular classification
Pseudogene
01

Overview

Thymosin beta 10 pseudogene 2 (TMSB10P2) is classified as a pseudogene in the human genome, designated by the gene ID 100873786[4][2]. Pseudogenes are genomic DNA sequences similar to normal genes but are nonfunctional; they are typically not transcribed into functional proteins and generally lack known biological function, disease relevance, or use as therapeutic targets[4][2]. TMSB10P2 is distinct from the protein-coding gene Thymosin beta 10 (TMSB10), which is involved in cytoskeletal organization and implicated in several cancers, but TMSB10P2 itself does not encode a functional protein and has no reported biological or clinical significance as a drug target[4][2].\n\nKey Context:\n- TMSB10P2 is a pseudogene related to TMSB10, but the functional and clinical data available about TMSB10 do not apply to TMSB10P2.\n- There is no evidence that TMSB10P2 serves as a therapeutic or biological target, or that it is associated with disease mechanisms, drug interactions, or safety concerns[4][2].\n\nIf you intended to inquire about the protein-coding gene Thymosin beta 10 (TMSB10) rather than its pseudogene TMSB10P2, a distinct summary can be provided.

Other names
TMSB10P2

Beyond the preview

Go deeper on Thymosin beta 10 pseudogene 2 (TMSB10P2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Thymosin beta 10 pseudogene 2 (TMSB10P2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call